1,169 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Allakos Competitors or Alternatives

Allakos's top competitors include MacroGenics, Juno Therapeutics and IFM Therapeutics.

Unlock 17 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Allakos's company profile

Robert Alexander

CEO

73/100
190
$420.5M
$ < 1M
  • $420.5M
    $ < 1M
  • 190
    $420.5M
  • $ < 1M
  • 73/100
  • 190
  • $420.5M
  • $ < 1M
View ProfileView
1
Allakos's Competitor - MacroGenics logo

Eric Risser

President & CEO

82/100
430
$348.4M
$183M
  • $348.4M
    $183M
  • 430
    $348.4M
  • $183M
  • 82/100
  • 430
  • $348.4M
  • $183M
View ProfileView
2
Allakos's Competitor - Juno Therapeutics logo

CEO

- -
1,000 - 5,000
$1.5B
$100M - 500M
  • $1.5B
    $100M - 500M
  • 1,000 - 5,000
    $1.5B
  • $100M - 500M
  • - -
  • 1,000 - 5,000
  • $1.5B
  • $100M - 500M
View ProfileView
3
Allakos's Competitor - IFM Therapeutics logo

H. Martin Seidel

CEO

90/100
25 - 100
$113.5M
$100K - 5M
  • $113.5M
    $100K - 5M
  • 25 - 100
    $113.5M
  • $100K - 5M
  • 90/100
  • 25 - 100
  • $113.5M
  • $100K - 5M
View ProfileView
4
Allakos's Competitor - Patara Pharma logo

William Gerhart

Chairman & CEO

73/100
25 - 100
$56M
$100K - 5M
  • $56M
    $100K - 5M
  • 25 - 100
    $56M
  • $100K - 5M
  • 73/100
  • 25 - 100
  • $56M
  • $100K - 5M
View ProfileView
5
Allakos's Competitor - COUR Pharma logo

Dannielle Appelhans

President & CEO

- -
25 - 100
$185.2M
$100K - 5M
  • $185.2M
    $100K - 5M
  • 25 - 100
    $185.2M
  • $100K - 5M
  • - -
  • 25 - 100
  • $185.2M
  • $100K - 5M
View ProfileView
Allakos' top 20 competitors are MacroGenics, Juno Therapeutics, IFM Therapeutics, Dermamedics, Patara Pharma, COUR Pharma, Jounce, Cogent, bluebird bio, Endocyte, Celgene, NexImmune, Sorrento, Mustang Bio, Corvus, IM Therapeutics, AnTolRx, Aura, Aurora Biopharma, Inc and Novartis. Together they have raised over 18.0B between their estimated 89.3K employees. Allakos has 190 employees and is ranked 7th among it's top 10 competitors. The top 10 competitors average 4,473.

Allakos VS MacroGenics

MacroGenics is one of Allakos's top competitors. MacroGenics is a Public company that was founded in Rockville, Maryland in 2000. MacroGenics is in the Biotechnology field. MacroGenics has 240 more employees vs. Allakos.

Allakos VS Juno Therapeutics

Juno Therapeutics is perceived as one of Allakos's biggest rivals. Juno Therapeutics was founded in 2013 in Seattle, Washington. Juno Therapeutics competes in the Biotechnology industry. Juno Therapeutics generates $106M more revenue than Allakos.

Allakos VS IFM Therapeutics

IFM Therapeutics is a top competitor of Allakos. IFM Therapeutics's headquarters is in Boston, Massachusetts, and was founded in 2015. IFM Therapeutics competes in the Pharmaceuticals field. IFM Therapeutics generates ∞% of Allakos's revenue.

Looking for similar companies to Allakos?

Similar Companies

Health Care Services companies in Redwood City

See 83 companies 
Companies in Redwood City with employees in 25-100 range

See 1,063 companies 
Health Care Equipment & Services companies in Redwood City

See 188 companies 
Health Care Services companies in San Francisco Bay Area

See 5,181 companies 
Health Care Equipment & Services companies in San Francisco Bay Area

See 9,460 companies 
Health Care Services companies in California

See 21,806 companies 
Health Care Equipment & Services companies in California

See 37,943 companies 
Companies in San Francisco Bay Area with employees in 25-100 range

See 73,082 companies 
Health Care Services companies with employees in 25-100 range

See 93,587 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Allakos and Allakos's Competitors

September 16, 2026BioPharma Dive
Proceeds from the deal, which hands Novartis global rights to a technology developed by Sironax, will help advance three candidates that the startup sa...
September 15, 2026GlobalNewswire
NDA supported by positive results from the APEX pivotal trial demonstrating clinically meaningful responses and evidence of disease modification in pat...
September 16, 2026BioSpace
The TREM2 stabilizer failed to show efficacy in a Phase 2 trial of patients with early-stage ALS. This development follows two late-stage trial failure...
September 15, 2026Seeking Alpha
September 16, 2026MedCity News
Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective blood-brain barrier. The dea...
September 15, 2026Genomeweb
The therapy for GEP-NETs was the subject of a years-long patent battle with Novartis that ended in June....
September 15, 2026Seeking Alpha

Frequently Asked Questions about Allakos

  1. Who are Allakos's top competitors?

    Allakos's top 3 competitors are MacroGenics, Juno Therapeutics, IFM Therapeutics.

  2. Who is similar to Allakos?

    MacroGenics is the most similar to Allakos. Juno Therapeutics and IFM Therapeutics are also similar to Allakos.

  1. Are Allakos and MacroGenics competitors?

    Yes, MacroGenics is one of Allakos’s top competitors.